Friday December 15th 2017

Peginterferon Beta-1a Significantly Increases the Proportion of Patients with Freedom from Measured Disease Activity in Relapsing-Remitting Multiple…

CONCLUSIONS: Post-hoc analyses of ADVANCE showed that proportions of patients with FMDA were significantly higher with peginterferon beta-1a Q2W at Year 1, versus placebo and peginterferon beta-1a Q4W.Study Sponsored by: Biogen Idec Inc.Disclosure: Dr. Arnold has received personal compensation for activities with Acorda Therapeutics, Bayer Pharmaceuticals Corporation, Biogen Idec, Coronado Biosciences, EMD Serono, Genentech Inc., Genzyme Corporation, GlaxoSmithKline Inc., MedImmune, NeuroRx Research. Dr. Arnold has received research support from Bayer Pharmaceuticals Corporation. Dr. Kieseier has received personal compensation for activities with Bayer Pharmaceuticals Corp., Schering AG, Biogen Idec, Merck Serono, Novartis, Roche Diagnostics Corp., Sanofi-Aventis Pharmaceuticals Inc., and …

See original:  

Peginterferon Beta-1a Significantly Increases the Proportion of Patients with Freedom from Measured Disease Activity in Relapsing-Remitting Multiple…

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]